B. Masojć

发表

Breast cancer predisposing alleles in Poland

A. Jakubowska, J. Lubiński, S. Narod, 2005, Breast Cancer Research and Treatment.

Germline 657del5 mutation in the NBS1 gene in breast cancer patients

Maria Chosia, Rodney Scott, Anna Jakubowska, 2003, International journal of cancer.

Low prevalence of CDKN2A/ARF mutations among early-onset cancers of breast, pancreas and malignant melanoma in Poland

J. Kładny, R. Scott, A. Jakubowska, 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Exploring the Link between Germline and Somatic Genetic Alterations in Breast Carcinogenesis

J. Dopazo, A. Berenguer, M. Pujana, 2010, PloS one.

Association of common WRAP 53 variant with ovarian cancer risk in the Polish population

J. Lubiński, J. Gronwald, B. Górski, 2012, Molecular Biology Reports.

Serum Selenium Level and 10-Year Survival after Melanoma

A. Jakubowska, J. Lubiński, C. Cybulski, 2021, Biomedicines.

Locoregional relapse is a strong prognostic indicator of distant metastatic progression in breast cancer patients after negative sentinel lymph node biopsy

B. Masojć, A. Kram, M. Falco, 2020, The breast journal.

The diameter of metastasis in positive sentinel lymph node biopsy affects axillary tumor load in early breast cancer

T. Byrski, B. Masojć, A. Kram, 2019, Asia-Pacific journal of clinical oncology.

Variant alleles of the CYP1B1 gene are associated with colorectal cancer susceptibility

J. Kładny, R. Scott, J. Lubiński, 2010, BMC Cancer.

CYP1B1 and predisposition to breast cancer in Poland

R. Scott, A. Jakubowska, J. Lubiński, 2007, Breast Cancer Research and Treatment.

Association between early-onset breast and laryngeal cancers

R. Scott, J. Lubiński, P. Serrano-Fernández, 2006, Breast Cancer Research and Treatment.

Molecular type and maximal metastasis diameter influence risk of axillary recurrence in breast cancer patients after positive sentinel lymph node biopsy

B. Masojć, A. Kram, M. Falco, 2021, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Accelerated Partial Breast Irradiation with Intraoperative Radiotherapy Is Effective in Luminal Breast Cancer Patients Aged 60 Years and Older

B. Masojć, A. Czekała, M. Falco, 2022, Journal of personalized medicine.

Frequency of whole breast irradiation (WBRT) after intraoperative radiotherapy (IORT) is strongly influenced by institutional protocol qualification criteria.

B. Masojć, A. Kram, M. Falco, 2018, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

A common nonsense mutation of the BLM gene and prostate cancer risk and survival.

P. Jarzemski, A. Jakubowska, J. Lubiński, 2013, Gene.

Germline RECQL mutations are associated with breast cancer susceptibility

Aniruddh Kashyap, Jacek Majewski, Javad Nadaf, 2015, Nature Genetics.

Corrigendum: Germline RECQL mutations are associated with breast cancer susceptibility

W. Foulkes, A. Jakubowska, J. Lubiński, 2016, Nature Genetics.

Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population

J. Kładny, R. Scott, J. Lubiński, 2014, Molecular Biology Reports.

XPD Common Variants and their Association with Melanoma and Breast Cancer Risk

J. Kładny, C. Cybulski, T. Byrski, 2006, Breast Cancer Research and Treatment.

CDKN2A common variant and multi‐organ cancer risk—a population‐based study

R. Scott, J. Lubiński, S. Narod, 2006, International journal of cancer.

CDKN 2 A common variant and multi-organ cancer risk — a population-based study

R. Scott, J. Lubiński, S. Narod, 2006 .

R. Scott, A. Jakubowska, J. Lubiński, 2011, PloS one.

Utilization of a 3D printer to fabricate boluses used for electron therapy of skin lesions of the eye canthi

Wojciech Podraza, Karolina Jezierska, W. Podraza, 2016, Journal of applied clinical medical physics.

First recurrent large genomic rearrangement in the BRCA1 gene found in Poland.

R. Scott, J. Lubiński, C. Cybulski, 2014, Cancer epidemiology.

DNA and RNA analyses in detection of genetic predisposition to cancer

R. Scott, A. Jakubowska, J. Trubicka, 2008, Hereditary Cancer in Clinical Practice.

Clinical characteristics of laryngeal cancer in BRCA-1 mutation carriers.

T. Huzarski, P. Serrano-Fernández, B. Masojć, 2009, Anticancer research.

Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology

J. Kładny, R. Scott, A. Jakubowska, 2009, Breast Cancer Research and Treatment.

The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs

A. Jakubowska, J. Lubiński, S. Narod, 2005 .

A high proportion of founder BRCA1 mutations in Polish breast cancer families

A. Jakubowska, J. Lubiński, S. Narod, 2004, International journal of cancer.

Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland.

Anna Jakubowska, Bohdan Górski, Tomasz Byrski, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Breast Cancer Risk Reduction Associated with the RAD 51 Polymorphism among Carriers of the BRCA 1 5382 insC Mutation in Poland 1

A. Jakubowska, J. Lubiński, S. Narod, 2003 .

BRCA1/2 mutations are not a common cause of malignant melanoma in the Polish population

D. Murawa, R. Scott, J. Lubiński, 2018, PloS one.

Founder Mutations for Early Onset Melanoma as Revealed by Whole Exome Sequencing Suggests That This is Not Associated with the Increasing Incidence of Melanoma in Poland

D. Murawa, R. Scott, J. Lubiński, 2018, Cancer research and treatment : official journal of Korean Cancer Association.

PALB2 mutations and prostate cancer risk and survival

P. Jarzemski, A. Jakubowska, S. Narod, 2021, British Journal of Cancer.

Inherited NBN Mutations and Prostate Cancer Risk and Survival

A. Jakubowska, J. Lubiński, C. Cybulski, 2018, Cancer research and treatment : official journal of Korean Cancer Association.

The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish men

A. Jakubowska, J. Lubiński, S. Narod, 2015, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Estrogen receptor status in CHEK2‐positive breast cancers: implications for chemoprevention

A. Jakubowska, J. Lubiński, C. Cybulski, 2009, Clinical genetics.

Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers.

A. Jakubowska, J. Lubiński, S. Narod, 2008, Carcinogenesis.

A novel founder CHEK2 mutation is associated with increased prostate cancer risk.

J. Lubiński, R. Czajka, S. Narod, 2004, Cancer research.

Advances in Brief A Novel Founder CHEK 2 Mutation is Associated with Increased Prostate Cancer Risk

J. Lubiński, R. Czajka, S. Narod, 2004 .

A Novel Founder CHEK 2 Mutation is Associated with Increased Prostate Cancer Risk

R. Czajka, S. Narod, C. Cybulski, 2004 .

R. Scott, A. Jakubowska, J. Lubiński, 2011 .

Risk factors for seroma evacuation in breast cancer patients treated with intraoperative radiotherapy.

B. Masojć, A. Czekała, A. Kram, 2016, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

The presence of prostate cancer at biopsy is predicted by a number of genetic variants

P. Jarzemski, A. Jakubowska, J. Lubiński, 2014, International journal of cancer.

Association of common WRAP 53 variant with ovarian cancer risk in the Polish population

J. Lubiński, J. Gronwald, B. Górski, 2012, Molecular Biology Reports.

Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.

A. Jakubowska, J. Lubiński, S. Narod, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genotyping by Induced Förster Resonance Energy Transfer (iFRET) Mechanism and Simultaneous Mutation Scanning

A. Jakubowska, J. Lubiński, C. Cybulski, 2013, Human mutation.

Genotyping by induced Förster Resonance Energy Transfer(iFRET) mechanism and simultaneous mutation scanning.

A. Jakubowska, J. Lubiński, C. Cybulski, 2013, Human mutation.

A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland

A. Jakubowska, J. Lubiński, S. Narod, 2007, Breast Cancer Research and Treatment.

Constitutional variants in POT1, TERF2IP, and ACD genes in patients with melanoma in the Polish population

R. Scott, J. Lubiński, C. Cybulski, 2020, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Prevalence of the E318K and V320I MITF germline mutations in Polish cancer patients and multiorgan cancer risk-a population-based study.

J. Kładny, R. Scott, J. Lubiński, 2014, Cancer genetics.

A range of cancers is associated with the rs6983267 marker on chromosome 8.

A. Jakubowska, J. Lubiński, S. Narod, 2008, Cancer research.

MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk

J. Kładny, R. Scott, J. Lubiński, 2006, International journal of cancer.

Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene

R. Scott, J. Lubiński, C. Cybulski, 2006, Breast Cancer Research and Treatment.

Low-risk Genes and Multi-organ Cancer Risk in the Polish Population

R. Scott, A. Jakubowska, J. Lubiński, 2006, Hereditary cancer in clinical practice.

Influence of the selenium level on overall survival in lung cancer.

R. Scott, A. Jakubowska, J. Lubiński, 2019, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.